Search

everythinglearnresearchcommunity

for

Search:↓

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

Male pattern baldness does not cause an increased risk of prostate cancer.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

The best animal model for studying male-pattern baldness is the stumptailed macaque, not rats or mice.

Fat stem cell treatment is safe and increases hair density for hair loss, but more research is needed.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The emulgel with specific ingredients was effective for treating hair loss.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Plant extracts may help treat hormone-related hair loss.

Men with early-onset hair loss have more heart disease risk factors.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Finasteride safely lowers DHT levels without affecting testosterone.

The Third World Congress of the International Academy of Cosmetic Dermatology discussed various topics like hair disorders, skin conditions, wound healing, shampoo technology, acne treatment, and the use of lasers in dermatology.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

In the Jazan region of Saudi Arabia, hair loss is common, especially among women, older people, and those with higher education and BMI. Stress, poor nutrition, and hormonal changes are key causes, but many don't seek medical help.